Consider participating in our Hypothyroidism research study for people aged 18-75 years. The study may be suitable for you if you have been taking daily Levothyroxine. Oher criteria apply. You may be compensated for your participation in the study.
The World Health Organization includes migraines as one of the 10 most debilitating medical conditions in the world affecting over 37 million in the U.S. alone. Accellacare is enrolling a research study evaluating an investigational preventive treatment of migraine in children and teens ages 6 – 17.
Accellacare is enrolling a research study evaluating an investigational medication for pain associated with post-surgical neuropathy. Eligible participants will receive study-related care and study medication at no cost.
The World Health Organization includes migraines as one of the 10 most debilitating medical conditions in the world affecting over 37 million in the U.S. alone. Accellacare has multiple options available to participate in migraine trials.
The World Health Organization includes migraines as one of the 10 most debilitating medical conditions in the world affecting over 37 million in the U.S. alone. Accellacare is enrolling a research study evaluating an investigational preventive treatment of migraine in children and teens ages 6 – 17.
This one-visit research study is evaluating blood samples collected from those with various types of thyroid/autoimmune diseases. Results will aid in understanding biomarkers associated with autoimmune thyroid diseases.
This one-visit research study is evaluating blood samples collected from those with various types of thyroid/autoimmune diseases. Results will aid in understanding biomarkers associated with autoimmune thyroid diseases.
Accellacare is enrolling a research study evaluating an investigational medication for agitation associated with Alzheimer's disease. Eligible participants will receive study-related care and study medication at no cost.
We are enrolling volunteers for a research study assessing the safety of an investigational medication for people who are overweight. People aged 18 years or over with a BMI of at least 27 who have a history of cardiovascular disease or chronic kidney disease may be eligible, other criteria apply. Compensation may be provided for time and travel expenses. Sign up to find out more.
Accellacare is enrolling adults for a vaccine research study. Eligible participants will receive study-related care and study vaccine at no cost. Financial compensation will also be provided for time and travel expenses.
Accellacare provides options for health adults over 18 to be a part of medical advancements. Eligible participants will receive study-related care and financial compensation for time and travel.
Accellacare provides options for health adults over 18 to be a part of medical advancements. Eligible participants will receive study-related care and financial compensation for time and travel.
Learn more about research opportunities in dermatology. Currently, Accellacare is looking for patients who are interested to participate in studies for a variety of skin conditions and ailments. Eligible participants will receive financial compensation and study related care at no cost. Refer an eligible friend to receive $50.
At Accellacare, we believe that the right to health is a cornerstone of human rights. On this Human Rights Day, we reflect on our responsibility to uphold these rights through ethical research and equitable practices.
Celebrate International Day of Persons with Disabilities 2024. Learn how supported independent living and advancements in clinical research foster inclusivity and independence for all.